Psoriasis and comorbidities in a southern Brazilian population: A case-control study

International Journal of Dermatology

Volumn 53, Issue 11, 2014, Pages e518-e525

  Menegon, Dóris B ^a,b   Pereira, Ana G ^a   Camerin, Anna C ^a   Cestari, Tania ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BLOOD PRESSURE; BODY MASS; BODY SURFACE; BRAZILIAN; CARDIOMETABOLIC RISK; CASE CONTROL STUDY; CLINICAL EVALUATION; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DIABETES MELLITUS; DISEASE ASSESSMENT; FEMALE; HEALTH HAZARD; HEART DISEASE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PHYSICAL EXAMINATION; PSORIASIS; QUESTIONNAIRE; SMOKING; WAIST CIRCUMFERENCE; BRAZIL; DRINKING BEHAVIOR; INCIDENCE; MIDDLE AGED; RISK FACTOR; SEVERITY OF ILLNESS INDEX;

ADULT; ALCOHOL DRINKING; BODY MASS INDEX; BRAZIL; CASE-CONTROL STUDIES; COMORBIDITY; DEPRESSION; DIABETES MELLITUS; FEMALE; HUMANS; HYPERTENSION; INCIDENCE; MALE; MIDDLE AGED; OBESITY; PSORIASIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SMOKING; WAIST CIRCUMFERENCE;

EID: 84911964688     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/ijd.12186     Document Type: Article

References (46)

1. Langley RG, Krueger GG, Griffiths CE. Psoriasis: epidemiology, clinical features, and quality of life. Ann Rheum Dis 2005; 64(Suppl. 2): 18-23. discussion 24-25.
2. Naldi L. Epidemiology of psoriasis. Curr Drug Targets Inflamm Allergy 2004; 3: 121-128.
3. Brazilian Society of Dermatology. Brazilian Consensus on Psoriasis, Vol 1. 1st edn. Rio de Janeiro: Brazilian Society of Dermatology, 2009: 5-12.
4. Ying W, Mills D, Bala M. Psoriasis: cardiovascular risk factors and other disease comorbidities. J Drugs Dermatol 2008; 7: 373-377.
5. Neimann AL, Shin DB, Wang X, et al. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 2006; 55: 829-835.
6. Gottlieb AB, Dann F, Menter A. Psoriasis and the metabolic syndrome. J Drugs Dermatol 2008; 7: 563-572.
7. Langan SM, Seminara NM, Shin DB, et al. Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom. J Invest Dermatol 2012; 132: 556-562.
8. Naldi L, Parazzini F, Brevi A, et al. Family history, smoking habits, alcohol consumption and risk of psoriasis. Br J Dermatol 1992; 127: 212-217.
9. Krueger G, Koo J, Lebwohl M, et al. The impact of psoriasis on quality of life. Arch Dermatol 2001; 137: 280-284.
10. Lund CC, Browder NC. The estimation of areas of burns. Surg Gynecol Obstet 1944; 79: 352-358.
11. National Cholesterol Education Program (NCEP) Expert Panel on Detection Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). The third report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adults Treatment Panel III). Circulation 2002; 106: 3143-3421.
12. McCulloch D. Screening for diabetes mellitus. 2008. Available at: http://www.uptodate.com (accessed 20 September 2009).
13. Gus I, Harzheim E, Zaslavsky C, et al. Prevalência, reconhecimento e controle da hipertensão arterial sistêmica no estado do Rio Grande do Sul. Arq Bras Cardiol 2004; 83: 424-428.
14. Gus I, Fischmann A, Medina C. Prevalência dos fatores de risco da doença arterial coronariana no estado do Rio Grande do Sul. Arq Bras Cardiol 2002; 78: 478-483.
15. National Institutes of Health. Clinical guidelines on identification, evaluation, and treatment of overweight and obesity in adults - the evidence report. Obes Res 1998; 6(Suppl. 2): 51-209.
16. Coordenação de Prevenção e Vigilância Inca/MS Ministério da Saúde Instituto Nacional do Câncer. Prevalência de Tabagismo no Brasil, Dados dos Inquéritos Epidemiológicos em Capitais Brasileiras. Rio de Janeiro, RJ: Ministério da Saúde, 2004.
17. Carlini E. Epidemiologia do uso do álcool no Brasil. Arq Med ABC 2006; 31(Suppl. 2): 4-7.
18. Cohen AD, Weitzman D, Dreiher J. Psoriasis and hypertension: a case-control study. Acta Derm Venereol 2010; 90: 23-26.
19. Sommer DM, Jenisch S, Suchan M, et al. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res 2006; 298: 321-328.
20. Augustin M, Reich K, Glaeske G, et al. Comorbidity and age-related prevalence of psoriasis: analysis of health insurance data in Germany. Acta Derm Venereol 2010; 90: 147-151.
21. Mebazaa A, El Asmi M, Zidi W, et al. Metabolic syndrome in Tunisian psoriatic patients: prevalence and determinants. J Eur Acad Dermatol Venereol 2011; 25: 705-709.
22. Shapiro J, Cohen AD, David M, et al. The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control study. J Am Acad Dermatol 2007; 56: 629-634.
23. Azfar RS, Gelfand JM. Psoriasis and metabolic disease: epidemiology and pathophysiology. Curr Opin Rheumatol 2008; 20: 416-422.
24. Kim GW, Park HJ, Kim HS, et al. Analysis of cardiovascular risk factors and metabolic syndrome in Korean patients with psoriasis. Ann Dermatol 2012; 24: 11-15.
25. Kremers HM, McEvoy MT, Dann FJ, et al. Heart disease in psoriasis. J Am Acad Dermatol 2007; 57: 347-354.
26. Menter A, Griffiths CE, Tebbey PH, et al. Exploring the association between cardiovascular and other disease-related risk factors in the psoriasis population: the need for increased understanding across the medical community. J Eur Acad Dermatol Venereol 2010; 24: 1371-1377.
27. Simonetti O, Ferretti G, Salvi A, et al. Plasma lipid changes in psoriatic children. Dermatology 1992; 185: 96-100.
28. Vahlquist C, Michaëlsson G, Vessby B. Serum lipoproteins in middle-aged men with psoriasis. Acta Derm Venereol 1987; 67: 12-15.
29. Naldi L. Cigarette smoking and psoriasis. Clin Dermatol 1998; 16: 571-574.
30. Setty AR, Curhan G, Choi HK. Smoking and the risk of psoriasis in women: Nurses' Health Study II. Am J Med 2007; 120: 953-959.
31. Cox N. Polymorphonuclear leukocytes in psoriatic smokers. Br J Dermatol 1989; 121: 143.
32. Poikolainen K, Reunala T, Karvonen J. Smoking, alcohol and life events related to psoriasis among women. Br J Dermatol 1994; 130: 473-477.
33. Fortes C, Mastroeni S, Leffondré K, et al. Relationship between smoking and the clinical severity of psoriasis. Arch Dermatol 2005; 141: 1580-1584.
34. Kirby B, Richards HL, Mason DL, et al. Alcohol consumption and psychological distress in patients with psoriasis. Br J Dermatol 2008; 158: 138-140.
35. Farkas A, Kemény L. Psoriasis and alcohol: is cutaneous ethanol one of the missing links? Br J Dermatol 2010; 162: 711-716.
36. Kimball AB, Guérin A, Tsaneva M, et al. Economic burden of comorbidities in patients with psoriasis is substantial. J Eur Acad Dermatol Venereol 2011; 25: 157-163.
37. O'Brien M, Koo J. The mechanism of lithium and beta-blocking agents in inducing and exacerbating psoriasis. J Drugs Dermatol 2006; 5: 426-432.
38. Ross R. Atherosclerosis is an inflammatory disease. Am Heart J 1999; 138: 419-420.
39. Hansson GK, Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 2006; 6: 508-519.
40. Pasceri V, Yeh ET. A tale of two diseases: atherosclerosis and rheumatoid arthritis. Circulation 1999; 100: 2124-2126.
41. Weyand CM, Goronzy JJ, Liuzzo G, et al. T cell immunity in acute coronary syndromes. Mayo Clin Proc 2001; 76: 1011-1020.
42. Mrowietz U, Kragballe K, Reich K, et al. Definition of treatment goals for moderate to severe psoriasis: a European consensus. Arch Dermatol Res 2011; 303: 1-10.
43. Winterfield LS, Menter A, Gordon K, et al. Psoriasis: current and emerging directed therapies. Ann Rheum Dis 2005; 64(Suppl. 2): 87-90.
44. Colombo G, Altomare G, Peris K, et al. Moderate and severe plaque psoriasis: cost-of-illness study in Italy. Ther Clin Risk Manag 2008; 4: 559-568.
45. Gelfand JM, Feldman SR, Stem RS, et al. Determinants of quality of life in patients with psoriasis: a study from the US population. J Am Acad Dermatol 2004; 51: 704-708.
46. Wollina U, Unger L, Heinig B, et al. Psoriatic arthritis. Dermatol Ther 2010; 23: 123-136.